全文获取类型
收费全文 | 92130篇 |
免费 | 6259篇 |
国内免费 | 1811篇 |
专业分类
耳鼻咽喉 | 1090篇 |
儿科学 | 1733篇 |
妇产科学 | 1637篇 |
基础医学 | 11922篇 |
口腔科学 | 3022篇 |
临床医学 | 8511篇 |
内科学 | 20864篇 |
皮肤病学 | 1856篇 |
神经病学 | 7357篇 |
特种医学 | 2485篇 |
外国民族医学 | 24篇 |
外科学 | 11575篇 |
综合类 | 4241篇 |
现状与发展 | 5篇 |
一般理论 | 38篇 |
预防医学 | 7509篇 |
眼科学 | 1897篇 |
药学 | 7023篇 |
12篇 | |
中国医学 | 1528篇 |
肿瘤学 | 5871篇 |
出版年
2024年 | 124篇 |
2023年 | 810篇 |
2022年 | 1152篇 |
2021年 | 2340篇 |
2020年 | 1538篇 |
2019年 | 1976篇 |
2018年 | 2936篇 |
2017年 | 1999篇 |
2016年 | 2078篇 |
2015年 | 3151篇 |
2014年 | 3378篇 |
2013年 | 4096篇 |
2012年 | 7792篇 |
2011年 | 7808篇 |
2010年 | 3885篇 |
2009年 | 2946篇 |
2008年 | 6317篇 |
2007年 | 6513篇 |
2006年 | 6688篇 |
2005年 | 6275篇 |
2004年 | 5507篇 |
2003年 | 5088篇 |
2002年 | 4814篇 |
2001年 | 2117篇 |
2000年 | 2565篇 |
1999年 | 1486篇 |
1998年 | 506篇 |
1997年 | 472篇 |
1996年 | 416篇 |
1995年 | 397篇 |
1994年 | 322篇 |
1993年 | 256篇 |
1992年 | 298篇 |
1991年 | 255篇 |
1990年 | 203篇 |
1989年 | 155篇 |
1988年 | 134篇 |
1987年 | 123篇 |
1986年 | 119篇 |
1985年 | 122篇 |
1984年 | 137篇 |
1983年 | 73篇 |
1982年 | 93篇 |
1981年 | 79篇 |
1980年 | 79篇 |
1979年 | 52篇 |
1978年 | 41篇 |
1977年 | 40篇 |
1976年 | 34篇 |
1974年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
15.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
16.
17.
18.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
19.
Annals of Nuclear Medicine - Cardiac amyloidosis is a rare disease characterized by amyloid heart deposits and is usually a part of systemic amyloidosis, in relation to systemic light chain (AL)... 相似文献
20.
Ragnhild B. Wijma Marloes Emous Merel van den Broek Anke Laskewitz Anneke C. Muller Kobold André P. van Beek 《Surgery for obesity and related diseases》2019,15(1):73-81